Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients

NCT04006652 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04006652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04006652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
December 16, 2020
Completion date
December 19, 2022
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft versus host disease, haploidentical hematopoietic stem cell transplant